<p>After the discovery of a new gene therapy for Huntington's, a devastating brain disease, Datshiane Navanayagam talks to one of the women in the UK who worked on it and a biologist from India who's made recent discoveries that could improve treatment for TB, which still kills over a million people globally each year.</p><p>Anne Rosser is Professor of Clinical Neuroscience at Cardiff University, combining both academic and clinical work specialising in patients with Huntington’s Disease. Huntington’s is an inherited condition caused by a faulty gene which stops the brain working properly, affecting mobility, learning, thinking and emotions. Anne also directs the Brain Repair Group in Cardiff.</p><p>Paridhi Sukheja is lead biologist for Tuberculosis drug discovery at Calibr-Skaggs Institute at Scripps Research in the US – a nonprofit research institute looking at drug discovery and treatments for diseases. TB is one of the world’s deadliest infectious diseases and, while widely treatable, it still kills 1.2 million people a year. Part of this is due to increasingly drug-resistant strains of the disease. Paridhi's work has been instrumental in the discovery of a potential new treatment for TB, including drug-resistant strains.</p><p>Produced by Jane Thurlow</p><p>(Image: (L) Paridhi Sukheja credit Nick Cusato. (R), Anne Rosser courtesy Anne Rosser.)</p>
